1Cines DB, Blanchette VS. Medical progress:immue thrombocytopenic purpura. N Engl J Med, 2002, 346:995-1008.
2Semple JW, Milev Y, Cosgrave D,et al. Difterences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity.Blood, 1996,87:4245-4254.
3Garcia-Suarez J, Prieto A, Reyes E, et al. Abnormal gamma IFN and alpha TNF secretion in purified CD2 + cells from autoimmune thrombocytopenic purpura (ATP) patients: their implication in the clinical course of the disease. Am J Hematol, 1995,49:271-276.
4Andersson J. Cytokines in idiopathic thrombocytopenic purpura(ITP). Acta Paediatr Suppl, 1998,424:61-64.
5Lazarus AH, Ellis J, Semple JW, et al. Comparison of platelet immunity in patients with SLE and ITP. Transfus Sci, 2000,22:19-27.
6Mouzaki A, Theodoropoulou M, Gianakopoulos I, et al. Expression patterns of Th1 and Th2 cytokine genes in childhood idiopathic thrombocytopenic purpura (ITP) at presentation and their modulation by intravenous immunoglobulinG (IVlg) treatment: their role in prognosis.Blood, 2002,1 O0 : 1774 - 1779.
7Olsson B, Andersson PO, Jernas M, et al. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura.Nat Med, 2003,9 : 1123-1124.
8Crossley AR, Dickinson AM, Proctor SJ, et al. Effects of interferonalpha therapy on immune parameters in immune thrombocytopenic purpura. Autoimmunity, 1996,24:81-100.
9Webber NP, Mascarenhas JO, Crow MK,et al. Functional properties of lymphocytes in idiopathic thrombocytopenic purpura. Hum Immunol, 2001,62 : 1346-1355.
10Andersson PO, Stockelberg D, Jacobsson S, et al. A transforming growth factor-betal-mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura. Ann Hematol, 2000,79:507-513.
